29.03.2013 Views

Proceedings of the International Cyanide Detection Testing Workshop

Proceedings of the International Cyanide Detection Testing Workshop

Proceedings of the International Cyanide Detection Testing Workshop

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

3)<br />

4)<br />

5)<br />

6)<br />

<strong>the</strong> metabolism <strong>of</strong> cyanide to ATCA must be demonstrated and if this is a metabolic<br />

pathway for fi sh <strong>the</strong> half-life <strong>of</strong> ATCA must be determined as well as <strong>the</strong> specie-to specie<br />

variation in half-life,<br />

<strong>the</strong> background level <strong>of</strong> cyanide in fi sh must be determined, if it is above <strong>the</strong> limit <strong>of</strong><br />

quantitation (LOQ) <strong>of</strong> <strong>the</strong> analysis technique, to defi ne when an elevated level due to<br />

cyanide exposure has been encountered.<br />

The background level <strong>of</strong> thiocyanate in fi sh must be determined, to defi ne if an exposure<br />

to cyanide will result in a statistically meaningful elevation <strong>of</strong> background thiocycante<br />

The background level <strong>of</strong> ATCA must be determined, if it is above <strong>the</strong> LOQ <strong>of</strong> <strong>the</strong><br />

analysis technique, to defi ne when an elevated level due to cyanide exposure has been<br />

encountered.<br />

To perform this research, validated methods for <strong>the</strong> determination <strong>of</strong> cyanide, thiocyanate and<br />

ATCA in homogenized fi sh tissue must be used. These methods must demonstrate adequate<br />

sensitivity, specifi city, accuracy and precision as determined by <strong>the</strong> “fi t for purpose” concept.<br />

3. Outline <strong>of</strong> Validation Procedure:<br />

3.1 Method validation is a process by which a laboratory confi rms by examination and <strong>the</strong><br />

provision <strong>of</strong> objective evidence that <strong>the</strong> particular requirements for specifi c use are fulfi lled.<br />

It serves to demonstrate that:<br />

3.1.1 The method can detect, identify and quantitate an analyte(s):<br />

• In all matracies to be analyzed<br />

• With a demonstrated sensitivity, specifi city, accuracy, reproducibility, ruggedness and<br />

precision to ensure that results are meaningful and appropriate for decision making<br />

by <strong>the</strong> receiving network.<br />

3.1.2 The method will function reliably for its intended purpose as defi ned by <strong>the</strong> network.<br />

3.2 The method developer validates a method by conducting experiments to determine or<br />

verify a number <strong>of</strong> specifi c performance characteristics that serve to defi ne and quantify<br />

method performance.<br />

4. Reference(s):<br />

4.1 Food and Drug Administration, Laboratory Manual, ORA Laboratory Procedure, Volume<br />

II, ORA-LAB5.4.5, Methods, Method Verifi cation and Validation<br />

4.2 <strong>International</strong> ANS/ISO/IEC Guide to <strong>the</strong> Expression <strong>of</strong> Uncertainty in Measurement,<br />

1995<br />

4.3 <strong>International</strong> ANS/ISO/IEC Guide 2 (VIM), 2004<br />

4.4 <strong>International</strong> ANS/ISO/IEC Guide 8402, Quality Management and Quality Assurance<br />

65

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!